| The Clinical, Oncological, Functional and Surgical Outcomes of Patients Who Underwent Adrenalectomy | Ünsal EROĞLU,Murat Yavuz KOPARAL,İYİMSER ÜRE,Serhat ÇETİN,Ender Cem BULUT,Cenk ACAR,Tevfik Sinan SÖZEN | 129–135 |
| The Presence and Thickness of Pseudocapsule after Partial Nephrectomy in Renal Cell Carcinoma | Fehmi NARTER,FATİH TARHAN,Emre ÇAMUR,Şükran SARIKAYA,Kayhan BAŞAK,Murat TUNCER,İstem KÖSE,Aydın ÖZGÜL | 136–139 |
| Use of a Polytetrafluoroethylene Teflon Felt During Partial Nephrectomy | Güven ASLAN,Ahmet CİHAN,Önder ÇINAR,Ömer DEMİR,Aykut KEFİ,İlhan ÇELEBİ | 140–143 |
| İmmünohistokimyasal Çalışma ile Prostat Karsinomunda Siklooksijenaz-2 Ekspresyonunun: Apopitozis ve Anjiyogenezis ile İlişkisi | EMİNE KILIÇ BAĞIR,Arbil AÇIKALIN,VOLKAN İZOL,Gülşah ŞEYDAOĞLU,ŞEYDA ERDOĞAN | 144–147 |
| Preoperative Factors Related to Stage and Grade Increase in D'Amico Low-Risk and Intermediate-Risk Group Patients | Serdar ÇELİK,Ozan BOZKURT,Ömer DEMİR,EMİNE BURÇİN TUNA,KUTSAL YÖRÜKOĞLU,Güven ASLAN | 148–153 |
| Preoperative Factors Related to Stage and Grade Increase in D'Amico Low-Risk and Intermediate-Risk Group Patients | Burçin TUNA, Kutsal YÖRÜKOĞLU, Ozan BOZKURT, Serdar ÇELİK, Güven ASLAN, Ömer DEMİR | 148–153 |
| Risk Factors for Urothelial Cancers | ÜMİT GÜL,Barış KUZGUNBAY | 154–158 |
| Information about Prostate Cancer for Urologist: Ga-68 Prostate Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Scintigraphy | Levent KABASAKAL | 159–162 |
| Active Surveillance in Prostate Cancer: Can We Expand the Indications? | Hacı Murat AKGÜL,Asgar GARAYEV,İLKER TİNAY | 163–166 |
| Bladder Leiomyoma in Men: Report of Two Cases and Review of the Literatüre | Özgür ÇAKMAK,Sevgi VERMİŞLİ,Okan Nabi YALBUZDAĞ,Dudu SOLAKOĞLU KAHRAMAN,Samir ABDULLAZADE | 167–169 |
| Bellini Duct Carcinoma: Case Report and Review of the Literature | Gökçe DÜNDAR,ESAT KORĞALI | 170–173 |